February 24, 2026
In this interview, Dr. Siddharth Kaul, Principal Investigator at CRP, shared how new tests for amyloid and tau proteins are transforming early detection of Alzheimer's disease and reshaping clinical trials. Watch the full segment from KMOV-TV.
November 19, 2025
Modern medical outpatient buildings (MOBs) are emerging as critical hubs for clinical research. This piece highlights our recent acquisition agreement with THL Partners. Read more in Drug Discovery & Development.
August 18, 2025
Headlands has been scooped up by private equity firm THL Partners, which entered an agreement to buy the clinical trial company from founding firm KKR, THL announced in an Aug. 14 release. Read more in this article from Fierce Biotech.
August 18, 2025
THL Partners has agreed to acquire Headlands Research in a strategic move that will accelerate our growth and strengthen our centralized infrastructure and technology. Learn more in this article from Clinical Trials Arena.
August 14, 2025
Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research. THL has been active in pharma services for more than two decades. Learn more in this article from Reuters.
July 7, 2025
Our recent acquisition of CMRCenter in San Juan, Puerto Rico, strengthens our global reach and unites CMRC’s local expertise with our centralized quality systems and investment in technology. Read more in this article from Fierce Biotech.
July 5, 2025
Our acquisition of CMRCenter in Puerto Rico marks an exciting milestone in our continued growth. Read more in the full article from MSN.
July 4, 2025
We're proud to welcome CMRCenter in San Juan, Puerto Rico, and its outstanding team to our growing network of sites. Read more in this article from Clinical Trials Arena.
June 23, 2025
Dr. Timothy Bailey, Founder and Site President at AMCR Institute, played a pivotal role in validating LifeLeaf, the world's first non-invasive glucose and cuffless BP monitoring device and platform. Read the full article from MedPath.
February 28, 2025
Mary Sullivan from Clinical Research Professionals, a Headlands Research site, has been honored with the 2024 Citizen Scientist Champion Award by the Global Alzheimer’s Platform Foundation (GAP). Read the full press release from GAP.
February 28, 2025
When Tammy Carmen, 77, decided to take a proactive approach to her cognitive health, she turned to Richmond Clinical Trials, a Headlands Research site, for a memory assessment. Read more in this article from Richmond News.
January 30, 2025
The mayor of Edinburg, Texas, Ramiro Garza, announced Wednesday that he was diagnosed with prostate cancer. Read more about the prognosis from Dr. Christopher Romero, Principal Investigator (PI) at Headlands Research Brownsville, in this KRGV.com article.
January 29, 2025
Last week, the Association of Multisite Research Corporations (AMRC) officially launched with 14 multisite clinical research corporations (MCRCs) members, including Headlands Research. Learn more from Jim Kremidas, AMRC executive director, in this article from Clinical Leader.
January 23, 2025
The Association of Multisite Research Corporations (AMRC) launched today, representing 14 founding organizations, including Headlands Research. Learn more in this article from Fierce Biotech.
November 11, 2024
Headlands Research recently acquired Trial Management Associates, a clinical research firm with locations in the Carolinas. Learn more in this article from the Greater Wilmington Business Journal.
September 27, 2024
The Lower Rio Grande Valley has one of the highest obesity rates in the United States, which, according to Dr. Christopher Romero, PI at Headlands Research Brownsville, can be, in part, attributed to a genetic component for Indigenous Americans. Learn more in this article from My RGV.
September 24, 2024
Headlands Research is launching its newest site on the U.S.-Mexico border in El Paso, Texas. Learn more about the site opening in this article from Fierce Biotech.
September 2, 2024
Sepsis is a medical emergency that kills nearly 270,000 Americans yearly. However, only 55% of Americans have heard of it. Learn more about the disease from Dr. Christopher Romero, Principal Investigator (PI) at Headlands Research Brownsville, in this article from Valley Central.
July 16, 2024
Earlier this year, Headlands Research CEO, Kyle Burtnett joined other experts as a panelist for a discussion on Clinical Trial Site Management Organizations (SMOs) during a session at the inaugural Pharma and MedTech Services Investment Summit. Learn more in this article from McDermott Will & Emery.
June 12, 2024
Drinking water, daily exercise, and a healthy diet are three lifestyle changes men can make to improve their health. Read more from Dr. Christopher Romero, Medical Director for Headlands Research and Principal InvestigatorHeadlandsResearch Brownsville, in this article from MyRGV.
April 3, 2024
Headlands Research has opened its fifth and final research site under its multi-year partnership with Pfizer to increase the diversity of participants in clinical trials. Learn more in this article from Fierce Biotech.
February 29, 2024
Headlands Research has acquired Pharmasite Research. Learn more in this article from Fierce Biotech.
February 26, 2024
Belinda Russell, Dir. of Recruitment Strategy, at Headlands Research, discusses how to achieve inclusive clinical trial enrollment in this article from International Clinical Trials.
July 27, 2023
Headlands Research acquires AMCR Institute. Learn more in this article from Applied Clinical Trials.
June 28, 2023
Headlands Research taps Kyle Burtnett to replace Cathy Collins as CEO. Learn more in this article from Fierce Biotech.
May 10, 2023
Headlands Research acquires Clinvest Research. Learn more in this article from Applied Clinical Trials.
April 19, 2023
Headlands Research has acquired an established clinical research site, now known as Headlands Research Eastern Massachusetts. Learn more in this article from Fierce Biotech.
April 19, 2023
Headlands acquires clinical research site in Massachusetts. The company plans to expand its network of clinical trial sites throughout the year. Learn more in this article from Clinical Trials Arena.
April 19, 2023
Headlands Research acquires eastern Massachusetts–based research site. Learn more in this article from Applied Clinical Trials.
April 18, 2023
Headlands Research acquires established eastern Massachusetts–based research site specializing in neurodegenerative diseases. Learn more in this article from StreetInsider.com.
April 17, 2023
Artemis: Driving better clinical trial results through patient-focused methodology. Learn more in this article from Life Sciences Review.
March 24, 2023
California firm expands network with launch of metro Detroit-based clinical trial site. Learn more in this article from DBusiness.
May 20, 2022
Headlands, Pfizer collaborate to boost clinical trial diversity. Under the collaboration, the first trial site will be opened at a new facility of Headlands in Brownsville, Texas, US. Learn more in this article from Clinical Trials Arena.
May 20, 2022
ASCO, ACCC become latest to call for clinical trial diversity with 6 strategies for improving inclusion in cancer studies. Learn more in this article from Fierce Biotech.
May 19, 2022
Pfizer teams up with Headlands Research to launch trial sites in more diverse areas. Learn more in this article from Fierce Biotech.
May 19, 2022
Pfizer, Headlands Research partner to bring trials to highly diverse areas. Learn more in this article from BioSpace.
April 13, 2021
Backed by KKR & Co., Headlands Research has conducted clinical trials for multiple COVID-19 vaccine candidates. Learn more from the Wall Street Journal.
September 2, 2020
Man who lost 7 relatives to COVID-19 becomes first American to trial Oxford vaccine at Headlands Research Jem Research Institute in Lake Worth, Florida. Learn more in this article from CBS News.